Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck

Published:2021-06-21 Issue:10 Volume:26 Page:1822-1830
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Nishimura Ari,Yokota Tomoya^ORCID,Hamauchi Satoshi,Onozawa Yusuke,Shirasu Hiromichi,Kawabata Takanori,Ogawa Hirofumi,Onoe Tsuyoshi,Iida Yoshiyuki,Mukaigawa Takashi,Yasui Hirofumi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-021-01965-1.pdf

Reference32 articles.

1. Buglione M, Maddalo M, Mazzeo E et al (2015) Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors. Tumori J 101(5):585–592

2. Hamoir M, Schmitz S, Suarez C et al (2018) The current role of salvage surgery in recurrent head and neck squamous cell carcinoma. Cancers 10(8):267

3. Miyazaki T, Hasegawa Y, Hanai N et al (2013) Survival impact of pulmonary metastasectomy for patients with head and neck cancer. Head Neck 35(12):1745–1751

4. Pasalic D, Betancourt-Cuellar SL, Taku N et al (2020) Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer. Head Neck 42(8):1939–1953

5. Depenni R, Cossu Rocca M, Ferrari D et al (2019) Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting. Eur J Cancer 115:4–12

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival Outcome Superiority of Total Pharyngolaryngectomy Compared with Chemoradiotherapy for T4aM0 Hypopharyngeal Squamous Cell Carcinoma: A Nationwide Database Study of Japan;Annals of Surgical Oncology;2024-08-12

2. Multidisciplinary tumor board for head and neck cancer from the perspective of medical oncologists—optimizing its effectiveness;Frontiers in Oncology;2023-08-30

3. Eligibility for Photoimmunotherapy in Patients with Unresectable Advanced or Recurrent Head and Neck Cancer and Changes before and after Systemic Therapy;Cancers;2023-07-26

4. Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab;International Journal of Clinical Oncology;2023-07-08

5. Transnasal photoimmunotherapy with cetuximab sarotalocan sodium: Outcomes on the local recurrence of nasopharyngeal squamous cell carcinoma;Auris Nasus Larynx;2022-06